Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This mix-up may help explain why cancer drugs aren’t always as effective as hoped.
Task force says some women can benefit from risk-reducing drugs like tamoxifen, but women at average risk should not take them.
A large analysis finds hormone replacement therapy increases the risk about twice as much as previously thought.
Many cancer survivors who undergo mastectomy can’t afford reconstruction surgery. But help is available.
Experts advise screening for those with a personal or family history of breast or ovarian cancer, but not for all women.
Women with a genetic tendency to wake up early may be protected against this cancer.
But much needs to be done to help cancer survivors live longer and healthier lives.
Researchers believe specially designed cancer care programs could prevent Black patients from being lost to care.
Doctors are more likely to order breast and colorectal cancer screenings earlier in the day.
Benefits stem not from fewer cancers but from preventing tumors from progressing.
The FDA does not believe that, on the basis of all available information, textured implants meets the banning standard.
An annual campaign to increase awareness of the disease.
Proposed rule would require breast density reporting and enhance the FDA’s ability to enforce compliance.
A set of mouse studies shows that this dietary intervention could be groundbreaking for breast cancer research.
Some women should start screening earlier because they are at higher risk for developing breast cancer or having more aggressive disease.
Read books on being diagnosed with cancer and much more.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.